Panelists Will Discuss Challenges Facing Personalized Medicine

The Personalized Medicine Coalition (PMC) will present a panel discussion on The Case for Personalized Medicine, on Wednesday, November 16, 2011, 4:00 pm – 7:00 pm, at the North Carolina Biotechnology Center, 15 T.W. Alexander Drive, Research Triangle Park.

Jennie Hunter-Cevera, PhD, Executive Vice President, RTI International, will serve as the moderator for the panel discussion.  Panelists include:

            Amy Abernethy, MD, Director, Duke Cancer Research Program

            Peter Collins, PhD, Vice President, Diagnostics, GlaxoSmithKline

            David King, CEO, Laboratory Corporation of America

Registration is free for PMC members; non-members pay $25.

Register online at or at the door. The event is sponsored by RTI International.


Share this Post